alexa Flecainide versus Electrical Cardio Version in Patients with a Recent-Onset Atrial Fibrillation
ISSN: 2165-7548

Emergency Medicine: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Flecainide versus Electrical Cardio Version in Patients with a Recent-Onset Atrial Fibrillation

Diego Conde1*, NicolasLalor2, Leandro Rodriguez2 and Pablo Elissamburu2

1Chief of Emergency Care Section, Instituto Cardiovascular de Buenos Aires, Blanco Encalada 1543, 1428 Buenos Aires, Capital Federal, Argentina

2Staff Member of Clinical Cardiology Service, Instituto Cardiovascular de Buenos Aires, Blanco Encalada 1543, 1428 Buenos Aires, Capital Federal, Argentina

*Corresponding Author:
Diego Conde
Chief of Emergency Care Section
Instituto Cardiovascular de Buenos Aires
Blanco Encalada 1543, 1428 Buenos Aires
Capital Federal, Argentina
Tel: 5491163816339
Fax: 541147877533
E-mail: [email protected]

Received Date: June 25, 2013; Accepted Date: August 19, 2013; Published Date: August 21, 2013

Citation: Conde D, Lalor N, Rodriguez L, Elissamburu P (2013) Flecainide versus Electrical Cardio Version in Patients with a Recent-Onset Atrial Fibrillation. Emergency Med 3:150. doi:10.4172/2165-7548.1000150

Copyright: © 2013 Conde D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Introduction:
Flecainide is a Class IA drug according the European Guidelines for conversion of recent-onset atrial fibrillation in patients without structural heart disease. Electrical Cardio version is the first line in many centers in all over the world in this population. Up to the present no study has been conducted comparing Flecainide with Electrical Cardio version (EC) for conversion of recent-onset atrial fibrillation. The goal of our study was to compare the conversion rate of recent-onset AF, hospital stay length and adverse events in hemodynamically stable patients without structural heart disease treated with flecainide or EC.
Methods:
50 hemodynamically stable patients with recent onset AF without structural heart disease were included. 30 patients received oral loading dose of flecainide 300 mg and other 20 patients EC. Clinical and laboratory variables were recorded.
Results:
Baseline characteristics were similar in both groups. The conversion rate was 70% in the flecainide group and 100 % in the EC group (p<0.01). Hospital stay length was 432 minutes and 263 minutes in EC (p<0.05).There were no adverse events in both groups.
Conclusion:
The conversion rate of recent-onset AF was lower and hospital stay length was shorter in EC group compared with flecainide group with significantly statistical differences. In both groups were no adverse events.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords